Infective endocarditis – A review of current therapy and future challenges

Etiological, microbiological and epidemiological factors changed over time, but mortality rates remain high in infective endocarditis (IE). Healthcare-associated IE is nowadays responsible for a significant proportion of cases due to increasing numbers of cardiac devices. Cardiac implantable electro...

Full description

Saved in:
Bibliographic Details
Published inHellenic journal of cardiology Vol. 62; no. 3; pp. 190 - 200
Main Authors Rezar, Richard, Lichtenauer, Michael, Haar, Markus, Hödl, Georg, Kern, Jan Marco, Zhou, Zhichao, Wuppinger, Thomas, Kraus, Johannes, Strohmer, Bernhard, Hoppe, Uta C., Wernly, Bernhard
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.05.2021
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Etiological, microbiological and epidemiological factors changed over time, but mortality rates remain high in infective endocarditis (IE). Healthcare-associated IE is nowadays responsible for a significant proportion of cases due to increasing numbers of cardiac devices. Cardiac implantable electronic devices, transcatheter aortic valve replacement, and percutaneous valve repair are meanwhile used, especially in old and sick patients. In suspected IE modified Duke criteria, integrating clinical results, imaging, and biomarkers are traditionally applied. Newer imaging technologies such as multi-slice computed tomography, photon-emission computed tomography, and magnetic resonance imaging might add value to conventional echocardiography in diagnosis and management of IE. Treatment consists of long-term antibiotic therapy, infectiological source control and/or cardiac surgery. Recently, antibiotic parenteral outpatient regimens and partial oral treatment strategies were shown to shorten hospital stays in patients suffering from IE. However, it remains unclear how to best select patients for partial oral therapy. This review describes new trends in diagnosing, imaging, and treating IE in a changing patient collective with particular focus on patients with implantable cardiac devices. [Display omitted]
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1109-9666
2241-5955
2241-5955
DOI:10.1016/j.hjc.2020.10.007